Journal
NEUROMOLECULAR MEDICINE
Volume 11, Issue 3, Pages 153-161Publisher
HUMANA PRESS INC
DOI: 10.1007/s12017-009-8086-x
Keywords
miRNAs; Neurodegenerative disease; Alzheimer's disease; Parkinson's disease; Huntington's disease; Transplantation
Categories
Funding
- Intramural NIH HHS [Z01 AG000312-07, Z01 AG000314-07, Z01 AG000313-07] Funding Source: Medline
Ask authors/readers for more resources
MicroRNAS (miRNAs) have been suggested to play important roles in the central nervous system during development as well as disease. miRNAs appear to be dysregulated in a number of neurodegenerative diseases, developmental disorders, and as a result of stroke. Each miRNA has the ability to regulate hundreds of messenger RNA transcripts, both by causing degradation of the mRNA and by inhibition of protein translation. Recent findings suggest that it may eventually be possible to treat some neurological disorders by restoring or inhibiting miRNAs altered by disease pathology. Both viral delivery and administration of modified oligonucleotides mimicking or inhibiting specific miRNAs have been effective in model systems. Artificial miRNAs have also been generated for the repression of specific transcripts. Alteration of miRNA expression by disease and insult also holds the potential for improved diagnostic tools. Finally, miRNAs have been shown to control cellular proliferation and specification, suggesting that manipulation of miRNAs in cultured cells could result in more convenient generation of pure cell populations for transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available